对SpiN-Tec的安全性和免疫性,SpiN-Tec是针对COVID-19的基于T细胞的RBD-Nucleocapsid仿真疫苗
Gregório Guilherme Almeida1, Jorge Andrade Pinto2, Patrícia Machado Pinto3
1Centro de Tecnologia de Vacinas, Universidade Federal de Minas Gerais, Parque Tecnológico de Belo Horizonte, MG, Brazil; Instituto René Rachou, Fundação Oswaldo Cruz-Minas, Belo Horizonte, MG, Brazil.
Vaccine
|September 20, 2025
概括
新型Spin-Tec COVID-19疫苗增剂证明了安全性,并诱导了持久的免疫反应. 这种嵌合蛋白疫苗在I期临床试验中显示了抗体水平的增加和强大的T细胞活性.
科学领域:
- 疫苗学 疫苗学 疫苗学
- 免疫学 免疫学 免疫学
- 生物技术是生物技术.
背景情况:
- 由于COVID-19的流行,需要持续开发有效的疫苗.
- 补充疫苗对于维持人群免疫力来对抗不断演变的SARS-CoV-2变种至关重要.
- 斯皮恩-Tec是一种新型的化学重组蛋白质疫苗候选人.
研究的目的:
- 评估Spin-Tec疫苗作为COVID-19助推剂的安全性和反应性.
- 在I期临床试验中评估Spin-Tec的免疫性.
- 为了确定Spin-Tec诱导的免疫反应的持久性.
主要方法:
- 一个I期随机临床试验,涉及36名年龄在18-54岁之间的健康成年人.
- 参与者先前接种了两剂疫苗 (CoronaVacTM) 和一个强剂 (ComirnatyTM Bivalent BA.4/BA.5).
- 参与者被随机分配到接受Spin-Tec (20微克,60微克或100微克) 或CoviShieldTM.
主要成果:
- 发现SpiN-Tec是安全的,反应性概况与CoviShield相似.
- 观察到IgG水平对抗核 (N) 和尖 (S) 蛋白的剂量依赖的增加.
- 在接种疫苗后的270天内,Spin-Tec诱导了强大而持久的IFN-γ产生,特别是CD4+效应器记忆T细胞.
结论:
- 斯皮恩-泰克是安全且具有免疫原性的COVID-19增强剂疫苗候选人.
- 疫苗引起剂量依赖的抗体反应和持久的T细胞介导免疫.
- 斯皮恩-泰克显示出作为COVID-19增剂疫苗接种策略的可行选择的潜力.
更多相关视频
08:52Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant
Published on: May 27, 2011
17.7K
08:07A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain
Published on: July 25, 2022
3.0K
相关概念视频
01:29Coronavirus
Coronaviruses, including the severe acute respiratory syndrome coronavirus (SARS-CoV), are enveloped viruses characterized by their single-stranded, positive-sense RNA genome and helical nucleocapsid structure. The hallmark of these viruses is their club-shaped spike (S) glycoproteins that protrude from the viral envelope, facilitating attachment to host cells. Typically, coronaviruses infect the upper respiratory tract, often causing mild or asymptomatic disease. However, certain strains like...
01:29Respiratory Syncytial Virus Disease
Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...